[1]王亚玲,王昌明,李晓.复方斑蝥胶囊辅助治疗对胃癌患者临床疗效及外周血NLRP3炎性小体表达的影响[J].西部中医药,2022,35(07):72-75.[doi:10.12174/j.issn.2096-9600.2022.07.19]
 WANG Yaling,WANG Changming,LI Xiao.Clinical Effects of Compound Banmao Capsules Adjuvant Therapy in Treating Gastric Cancer and Its Influence on the Expressions of NLRP3 Inflammasome in Peripheral Blood[J].Western Journal of Traditional Chinese Medicine,2022,35(07):72-75.[doi:10.12174/j.issn.2096-9600.2022.07.19]
点击复制

复方斑蝥胶囊辅助治疗对胃癌患者临床疗效及外周血NLRP3炎性小体表达的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年07期
页码:
72-75
栏目:
衷中参西
出版日期:
2022-07-15

文章信息/Info

Title:
Clinical Effects of Compound Banmao Capsules Adjuvant Therapy in Treating Gastric Cancer and Its Influence on the Expressions of NLRP3 Inflammasome in Peripheral Blood
作者:
王亚玲1 王昌明1 李晓2
1.彭州市人民医院,四川 彭州 611930
2.成都医学院第一附属医院肿瘤科
Author(s):
WANG Yaling1 WANG Changming1 LI Xiao2
1.Pengzhou People's Hospital, Pengzhou 611930, China
2.Department of Oncology, the First Affiliated Hospital of Chengdu Medical College
关键词:
胃癌核苷酸结合寡聚化结构域样受体蛋白3白细胞介素1白细胞介素18复方斑蝥胶囊临床疗效
Keywords:
gastric cancerNLRP3IL-1IL-18compound capsulesclinical effects
分类号:
R256.39
DOI:
10.12174/j.issn.2096-9600.2022.07.19
文献标志码:
B
摘要:
目的观察复方斑蝥胶囊辅助治疗对胃癌患者临床疗效及外周血单个核细胞(peripheral blood mononuclear cells,PBMCs)中的核苷酸结合寡聚化结构域样受体蛋白3(nucleotide-binding oligomerization domain-like receptor protein 3,NLRP3)炎性小体表达的影响。 方法将胃癌患者110例按随机数字表法分为对照组和观察组各55例。对照组予FOLFOX4方案化疗,观察组在对照组基础上加用复方斑蝥胶囊辅助治疗。观察两组患者治疗前后PBMCs中NLRP3、半胱氨酸蛋白酶1(Caspase-1)的mRNA及蛋白表达、炎性细胞因子[白细胞介素1β(interleukin-1β,IL-1β)、白细胞介素18(interleukin-18,IL-18)]水平、临床疗效及不良反应发生情况。 结果两组患者治疗后外周血PBMCs中的NLRP3、Caspase-1 mRNA及蛋白表达水平均低于治疗前(P<0.05),观察组低于对照组(P<0.05)。与治疗前比较,两组患者治疗后外周血IL-1β和IL-18水平均较治疗前降低(P<0.05),观察组低于对照组(P<0.05)。总有效率观察组为74.55%,高于对照组的61.82%(P<0.05)。观察组治疗后Karnofsky评分改善和稳定的患者比例高于对照组,但差异无统计学意义(P>0.05)。两组患者不良反应发生率比较差异无统计学意义(P>0.05)。 结论复方斑蝥胶囊辅助治疗可有效降低胃癌患者NLRP3炎性小体的表达及炎症反应,提高临床疗效。
Abstract:
ObjectiveTo observe clinical effects of compound Banmao capsules adjuvant therapy in the treatment of gastric cancer and its influence on the expressions of NLRP3 in peripheral blood mononuclear cells (PBMCs). MethodsAll 110 patients were separated to the control group and the observation group according to random number table method. The control group accepted FOLFOX4 regimen chemotherapy, and the observation group received compound Banmao capsules adjuvant therapy based on chemotherapy. To observe the expressions of NLRP3 and Caspase-1 mRNA and protein in PBMCs, the levels of inflammatory cytokines [IL-1β, IL-18], clinical effects and the incidence of adverse reaction before and after treatment. ResultsThe expressions of NLRP3 and Caspase-1 mRNA and protein in PBMCs of both groups after the treatment were lower than these before treatment (P<0.05), the observation group was lower than the control group (P<0.05). Compared with before treatment, the levels of IL-1β and IL-18 in peripheral blood reduced after treatment in both groups compared with these before treatment (P<0.05), the observation group was lower than the control group (P<0.05). Total effective rate of the observation group was 74.55%, higher than 61.82% of the control group (P<0.05). After the treatment, the proportion of the patients with Karnofsky improvement and stabilization in the observation group was higher than that of the control group, while the difference had no statistical meaning (P>0.05). The difference had no statistical meaning in the incidence of adverse reaction between both groups (P>0.05). ConclusionCompound Banmao capsules adjuvant therapy could effectively lower the expressions of NLRP3 and inflammatory reaction in patients with gastric cancer, and raise clinical effects.

相似文献/References:

[1]熊墨年,唐晓玲,余炅,等.益气清毒法联合化疗治疗中晚期胃癌的临床观察[J].西部中医药,2011,24(11):35.
[2]张小仙,倪角角,陈辉.舒适护理在晚期胃癌患者中的应用[J].西部中医药,2012,25(12):105.
 ZHANG Xiao-xian,NI Jiao-jiao,CHEN Hui.Application of Comfort Care to the Patients with Gastric Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(07):105.
[3]王宏伟,程小丽,许雅清,等.苦马豆素对胃癌细胞中pten和survivin mRNA表达的影响[J].西部中医药,2015,28(12):25.
[4]胡玥,刘沈林.刘沈林教授“胃肾同治”理论探讨及其在胃癌中的应用[J].西部中医药,2015,28(10):72.
[5]朱剑梅,李世军.莲芪胶囊配合化疗治疗胃癌的临床研究[J].西部中医药,2015,28(12):91.
[6]李雅娟.围手术期护理对胃癌根除术患者护理质量的影响[J].西部中医药,2012,25(12):113.
 LI Ya-juan.Influence of Perioperative Care on Nursing Quality of Patients Undergoing Radical Resection of Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(07):113.
[7]刘河,刘超,杨世勇.胃癌中医证型与病灶组织中MMP-9、TIMP-2和HER-2表达的相关性分析[J].西部中医药,2017,30(02):134.
 LIU He,LIU Chao,YANG Shiyong.Correlation Analysis btween TCM Syndrome of Gastric Cancer and the Expression of MMP-9, TIMP-2 and HER-2 in Focus Tissue[J].Western Journal of Traditional Chinese Medicine,2017,30(07):134.
[8]王志新,邹玺,胡守友.中药抗胃癌的现代药理机制[J].西部中医药,2016,29(04):137.
 WANG Zhixin,ZOU Xi,HU Shouyou.Modern Pharmacological Mechanism of Herbs Fighting against Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2016,29(07):137.
[9]白兆琴,王惠霞,王宏伟△.黄芩苷对胃癌SGC-7901细胞TLR8、HIF-1α、PDGFβ和pten表达的影响[J].西部中医药,2017,30(08):12.
 BAI Zhaoqin,WANG Huixia,WANG Hongwei.The Effects of Baicalin on the Expression of TLR8, HIF-1α, PDGFβ and pten of Gastric Cancer SGC-7901 Cells[J].Western Journal of Traditional Chinese Medicine,2017,30(07):12.
[10]王亚峰,谢亲建,丁晓煜,等.白刺对胃癌MGC-803细胞的抑制作用[J].西部中医药,2018,31(05):14.
 WANG Yafeng,XIE Qinjian,DING Xiaoyu,et al.Study of Inhibitory Action of BaiCi on Gastric Cancer MGC-803 Cells[J].Western Journal of Traditional Chinese Medicine,2018,31(07):14.

备注/Memo

备注/Memo:
王亚玲(1979—),女,硕士学位,副主任医师。研究方向:胃癌的临床研究。四川省教育厅科研项目(16TD0028)。
更新日期/Last Update: 2022-07-15